IMMUNITYBIO INC (IBRX) Stock Cash Flow
NASDAQ:IBRX - Nasdaq - US45256X1037 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -587.88M | -583.85M | -417.32M | -349.85M | -224.19M | |||
| Depreciation Amortization | 17.98M | 18.51M | 18.26M | 14.24M | 12.74M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | -10.00K | -2.94M | |||
| Change In Working Capital | -34.33M | 3.98M | -8.00M | -19.11M | 16.36M | |||
| Interest Paid | 115.74M | 77.19M | 35.44M | 2.11M | 40.00K | |||
| Taxes Paid | 23.00K | 8.00K | 0.00 | 10.00K | 10.00K | |||
| Other non cash items | 182.87M | 194.61M | 69.56M | 80.31M | 26.30M | |||
| OPERATING CASH FLOW | -421.36M | -366.76M | -337.51M | -274.42M | -171.72M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -12.73M | -30.58M | -99.39M | -33.56M | -1.67M | |||
| Other Investing Activity | -7.10M | 114.00K | 126.69M | -51.32M | -18.14M | |||
| INVESTING CASH FLOW | -19.83M | -30.47M | 27.30M | -84.89M | -19.81M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 289.64M | 451.39M | 174.13M | 338.50M | 63.70M | |||
| Stock Issued/Repurchased | 85.60M | 106.95M | 59.89M | 165.93M | 86.98M | |||
| Other Financing Activity | N/A | 0.00 | -400.00K | 1.02M | 0.00 | |||
| FINANCING CASH FLOW | 375.24M | 558.34M | 233.61M | 505.44M | 150.68M | |||
| Exchange Rate Effect | -43.00K | -292.00K | 280.00K | 50.00K | -30.00K | |||
| CHANGE IN CASH | -66.00M | 160.82M | -76.32M | 146.18M | -40.88M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -421.36M | -366.76M | -337.51M | -274.42M | -171.72M | |||
| Capital Expenditure | -12.73M | -30.58M | -99.39M | -33.56M | -1.67M | |||
| FREE CASH FLOW | -434.10M | -397.34M | -436.90M | -307.98M | -173.39M | |||
All data in USD